Home
AVDL
AVDL News

Latest Avadel Pharmaceuticals plc (AVDL) News on January 29, 2025

Argus Research

19 hours ago

Daily – Vickers Top Insider Picks for 01/28/2025

Argus Research

2 days ago

Daily – Vickers Top Insider Picks for 01/27/2025

Argus Research

5 days ago

Daily – Vickers Top Insider Picks for 01/24/2025

Argus Research

6 days ago

Daily – Vickers Top Insider Picks for 01/23/2025

Argus Research

6 days ago

Daily – Vickers Top Buyers & Sellers for 01/23/2025

Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement

GlobeNewswire

7 days ago

Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement

Argus Research

7 days ago

Daily – Vickers Top Insider Picks for 01/22/2025

Argus Research

8 days ago

Daily – Vickers Top Insider Picks for 01/21/2025

Argus Research

12 days ago

Daily – Vickers Top Insider Picks for 01/17/2025

Argus Research

13 days ago

Daily – Vickers Top Insider Picks for 01/16/2025

Argus Research

14 days ago

Daily – Vickers Top Insider Picks for 01/15/2025

Argus Research

14 days ago

Daily – Vickers Top Buyers & Sellers for 01/15/2025

MT Newswires

16 days ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $14 From $22, Maintains Buy Rating

MT Newswires

20 days ago

Needham Adjusts Avadel Pharmaceuticals' Price Target to $19 From $22, Keeps Buy Rating

GuruFocus.com

20 days ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

MT Newswires

20 days ago

Avadel Pharmaceuticals Preliminary Q4 Net Product Revenue Rises; 2025 Outlook Set; Shares Fall After Hours

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch

GlobeNewswire

20 days ago

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Expect

GuruFocus.com

22 days ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Expect

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

22 days ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8

GlobeNewswire

a month ago

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8

Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock

Simply Wall St.

2 months ago

Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock

Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy

GlobeNewswire

2 months ago

Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy

MT Newswires

2 months ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $22 From $25, Maintains Buy Rating

Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

2 months ago

Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

GlobeNewswire

3 months ago

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

GuruFocus.com

3 months ago

Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ...

MT Newswires

3 months ago

Avadel Pharmaceuticals' Q3 Loss Narrows, Revenue Rises

Associated Press Finance

3 months ago

Avadel: Q3 Earnings Snapshot

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

3 months ago

Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12

GlobeNewswire

3 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12

US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle

Pharmaceutical Technology

3 months ago

US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle

Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term

Simply Wall St.

3 months ago

Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation

GlobeNewswire

3 months ago

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation

Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances

GlobeNewswire

3 months ago

Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances

Avadel wins FDA approval for narcolepsy drug Lumryz in children

Pharmaceutical Technology

3 months ago

Avadel wins FDA approval for narcolepsy drug Lumryz in children

Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz

Zacks

3 months ago

Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz

MT Newswires

3 months ago

Avadel Pharmaceuticals Gets FDA Approval for Lumryz to Treat Cataplexy in Narcolepsy Patients

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

GlobeNewswire

3 months ago

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

GuruFocus.com

4 months ago

Avadel Pharmaceuticals PLC (AVDL) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent

GlobeNewswire

4 months ago

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent

Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)

GlobeNewswire

5 months ago

Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)

MT Newswires

5 months ago

Sector Update: Health Care

MT Newswires

5 months ago

Avadel Pharma Shares Fall After Split Decision in Legal Fight Over Narcolepsy Drug

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire

5 months ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Avadel Pharmaceuticals plc (AVDL): One of Oppenheimer’s Top Stock Picks For the Next 12 Months

Insider Monkey

5 months ago

Avadel Pharmaceuticals plc (AVDL): One of Oppenheimer’s Top Stock Picks For the Next 12 Months

Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension

GlobeNewswire

5 months ago

Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension

MT Newswires

6 months ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $25 From $23, Maintains Buy Rating

MT Newswires

6 months ago

Avadel Pharmaceuticals Narrows Q2 Net Loss as Product Revenue Climbs

Are Medical Stocks Lagging DaVita (DVA) This Year?

Zacks

6 months ago

Are Medical Stocks Lagging DaVita (DVA) This Year?

Associated Press Finance

6 months ago

Avadel: Q2 Earnings Snapshot

Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82

Investor's Business Daily

6 months ago

Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82

Does Avadel (AVDL) Have the Potential to Rally 43.6% as Wall Street Analysts Expect?

Zacks

6 months ago

Does Avadel (AVDL) Have the Potential to Rally 43.6% as Wall Street Analysts Expect?

Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Results on August 8

GlobeNewswire

6 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Results on August 8

Avadel announces first subject dosing in Phase III idiopathic hypersomnia trial

Clinical Trials Arena

6 months ago

Avadel announces first subject dosing in Phase III idiopathic hypersomnia trial

Avadel Pharmaceuticals Announces First Patient Dosed in Phase 3 REVITALYZ™ Trial of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

GlobeNewswire

6 months ago

Avadel Pharmaceuticals Announces First Patient Dosed in Phase 3 REVITALYZ™ Trial of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

MT Newswires

7 months ago

Avadel Pharmaceuticals to Join Russell 3000 Index Monday; Shares Rise After Hours

Avadel Pharmaceuticals to Join Russell 3000® Index

GlobeNewswire

7 months ago

Avadel Pharmaceuticals to Join Russell 3000® Index

Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?

Zacks

7 months ago

Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?

VanEck Semiconductor ETF Is Riskier Than You Think

Motley Fool

8 months ago

VanEck Semiconductor ETF Is Riskier Than You Think

A Wall Street Analyst Just Predicted Nvidia Would Hit a $10 Trillion Market Cap. Is That Actually Possible?

Motley Fool

8 months ago

A Wall Street Analyst Just Predicted Nvidia Would Hit a $10 Trillion Market Cap. Is That Actually Possible?

Norway wealth fund to vote against Musk's $56 billion Tesla pay package

Reuters

8 months ago

Norway wealth fund to vote against Musk's $56 billion Tesla pay package

Oberstdorfer Bergbahn Reports Full Year 2023 Earnings

Simply Wall St.

8 months ago

Oberstdorfer Bergbahn Reports Full Year 2023 Earnings

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

GuruFocus.com

8 months ago

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

Insider Sale: CFO Steven Tomsic Sells 30,000 Shares of Fox Corp (FOX)

GuruFocus.com

8 months ago

Insider Sale: CFO Steven Tomsic Sells 30,000 Shares of Fox Corp (FOX)

Insider Sale: Chief Legal Officer Jeff Lendino Sells Shares of Jamf Holding Corp (JAMF)

GuruFocus.com

8 months ago

Insider Sale: Chief Legal Officer Jeff Lendino Sells Shares of Jamf Holding Corp (JAMF)

Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)

GuruFocus.com

8 months ago

Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire

8 months ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024

GlobeNewswire

8 months ago

Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024

Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors

GlobeNewswire

8 months ago

Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript

MT Newswires

9 months ago

Avadel Pharmaceuticals Q1 Loss Narrows

Avadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...

GuruFocus.com

9 months ago

Avadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...

Associated Press Finance

9 months ago

Avadel: Q1 Earnings Snapshot

Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results

GlobeNewswire

9 months ago

Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8

GlobeNewswire

9 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8

Wall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Know

Zacks

9 months ago

Wall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Know

11 Best Low Price Pharma Stocks To Invest In

Insider Monkey

9 months ago

11 Best Low Price Pharma Stocks To Invest In

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near Future

Simply Wall St.

10 months ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near Future

Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

GlobeNewswire

10 months ago

Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire

a year ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Avadel Pharmaceuticals Issues Statement On Patent Litigation

GlobeNewswire

a year ago

Avadel Pharmaceuticals Issues Statement On Patent Litigation

Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

a year ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

With 62% ownership, Avadel Pharmaceuticals plc (NASDAQ:AVDL) boasts of strong institutional backing

Simply Wall St.

a year ago

With 62% ownership, Avadel Pharmaceuticals plc (NASDAQ:AVDL) boasts of strong institutional backing

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4

GlobeNewswire

a year ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4

Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

a year ago

Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

Business Wire

a year ago

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

First Financial Bank and National Community Reinvestment Coalition Announce $2.4 Billion Community Benefits Agreement

PR Newswire

a year ago

First Financial Bank and National Community Reinvestment Coalition Announce $2.4 Billion Community Benefits Agreement

Thoughtworks Named a Top 15 Sourcing Standout by ISG

Business Wire

a year ago

Thoughtworks Named a Top 15 Sourcing Standout by ISG

Investors in Rogers (NYSE:ROG) have unfortunately lost 25% over the last three years

Simply Wall St.

a year ago

Investors in Rogers (NYSE:ROG) have unfortunately lost 25% over the last three years

First Citizens BancShares, Inc. (NASDAQ:FCNCA) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

First Citizens BancShares, Inc. (NASDAQ:FCNCA) Q4 2023 Earnings Call Transcript

BankUnited Inc (BKU) Reports Decline in Quarterly and Annual Net Income Amid Strategic Balance ...

GuruFocus.com

a year ago

BankUnited Inc (BKU) Reports Decline in Quarterly and Annual Net Income Amid Strategic Balance ...

Columbia Financial (CLBK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

a year ago

Columbia Financial (CLBK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Mexico's Televisa close to launching sports and gaming spin-off

Reuters

a year ago

Mexico's Televisa close to launching sports and gaming spin-off

3 Mid-Cap Energy Stocks Investors Can Buy Right Now

Zacks

a year ago

3 Mid-Cap Energy Stocks Investors Can Buy Right Now

Is It Too Late to Buy Dutch Bros Stock?

Motley Fool

a year ago

Is It Too Late to Buy Dutch Bros Stock?

Pathward Financial, Inc. Announces Results for 2024 Fiscal First Quarter

Business Wire

a year ago

Pathward Financial, Inc. Announces Results for 2024 Fiscal First Quarter

Why Veeco (VECO) Could Beat Earnings Estimates Again

Zacks

a year ago

Why Veeco (VECO) Could Beat Earnings Estimates Again

Share on Social Networks: